http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014530238-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
filingDate 2012-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2014-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2014530238-A
titleOfInvention 8-Carbamoyl-2- (2,3-disubstituted pyrid-6-yl) -1,2,3,4-tetrahydroisoquinoline derivatives as apoptosis inducers for the treatment of cancer and immune and autoimmune diseases
abstract Disclosed are compounds of formula (I) that inhibit the activity of anti-apoptotic Bcl-xL protein, compositions comprising the compound, and methods for treating diseases in which Bcl-xL protein is expressed, such as cancer. X is heteroaryl; Y 1 is phenylene or heteroarylene; L 1 is a linking group; Y 2 is cycloalkyl, cycloalkenyl, heterocyclic alkyl or heterocyclic alkenyl; Z 1 is C (O ) OR 9 , C (O) NR 10 R 11 , C (O) R 11 , NR 10 C (O) R 11 and the like.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018502839-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019524651-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018506509-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018508463-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019528240-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020152726-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020128378-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020143062-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019521114-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019521975-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019524649-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019522643-A
priorityDate 2011-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010080503-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010080478-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013055895-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011139107-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466838873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465823506
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467126451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466675306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466681928
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466980918

Total number of triples: 51.